Dopamine Hydrochloride Injection
Product Images NDC 51662-1490
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Dopamine Hydrochloride (NDC 51662-1490). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Hs (Hs)
Serialized Label (Serialized Labeling)
Structure (Structure)
Vial (Vial Label)
This is an information on DOPamine Hydrochloride Injection, USP, a medication with NDC 0143-9254-01 for intravenous use, packaged in a 10 mL vial containing 400 mg of dopamine hydrochloride. The medication must be diluted and caution must be exercised in its use. Each mL of this medication contains sodium metabisulfite 9 mg added as a stabilizer, citric acid anhydrous 10 mg, and sodium citrate dehydrate 5 mg added as a buffer. This medication is sterile and nonpyrogenic. The manufacturer of the medication is Hikma Farmaceutica (Portugal) SA. Lot number and expiry date of the medication are not available.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.